First-line treatment for Pneumocystis jiroveci pneumonia is which therapy?

• A. Azithromycin
• B. Amphotericin B
• C. Itraconazole
• D. TMP-SMX

Answer: (D)

Pneumocystis jirovecii pneumonia is treated first with trimethoprim-sulfamethoxazole because this drug combination effectively blocks folate synthesis in the organism, a critical pathway for its DNA and replication. TMP-SMX provides strong activity against Pneumocystis and has good lung penetration, making it the preferred initial therapy. In more severe cases where oxygen levels are low, adding corticosteroids within a short time frame helps reduce inflammatory damage in the lungs and improves outcomes. The other agents listed are not effective first-line choices for this pneumonia: azithromycin is more for atypical bacteria, amphotericin B targets systemic fungi but not Pneumocystis efficiently, and itraconazole is used for certain fungal infections but not this organism.